The French government has secured commitments from Opella, a subsidiary of Sanofi, amid concerns over a US takeover by Clayton, Dubilier & Rice. The agreement mandates job and production retention in France, with penalties for non-compliance. This move aims to protect essential medicine supplies and maintain local employment.